Literature DB >> 27542871

MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.

Yan Liang1, Guoqiang Zhao2, Lin Tang1, Junjun Zhang1, Tianfang Li3, Zhangsuo Liu4.   

Abstract

IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis, characterized by mesangial deposition of pathogenic IgA and the injury to mesangial cells. Our previous studies indicate that secretory IgA (SIgA) plays an important role in the pathogenesis of IgAN, and miR-16 is involved in destructive process in mesangial cells mediated by the SIgA from IgAN patients. Our current study aimed to study the role of miRNAs in the effect of SIgA from IgAN patients on mesangial cells. MicroRNA microarray and cytokines assay were performed to obtain the differential microRNAs expression profile in human renal mesangial cells stimulated by SIgA from IgAN patients (P-SIgA) with the cells treated by SIgA from healthy subjects (N-SgA) as control. The microRNAs with the most significant differences in microarray analysis were validated by quantitative RT-PCR. Among them, miR-100-3p and miR-877-3p were selected to predict target gene related to cytokines detecting in this study. Fifty-six differentially expressed microRNAs were chosen and 17 microRNAs with the most prominent changes were validated. Compared with N-SIgA, P-SIgA increased the production of interleukin (IL)-1β, IL-8, monocyte chemotactic protein-1 and transforming growth factor-β1. In addition, we for the first time demonstrated that over-production of IL-8 induced by the SIgA was regulated by down-expression of miR-100-3p in mesangial cells. Similarly, IL-1β over-production was regulated by down-expression of miR-877-3p. Our findings represent a pathogenic microRNAs expression profiling in human mesangial cells activated by P-SIgA. Furthermore, we provide a new explanation characterizing the molecular mechanism responsible for the regulation of IL-1β and IL-8 production in P-SIgA-triggered mesangial cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IgA nephropathy; Mesangial cells; MiR-100-3p; MiR-877-3p; Secretory IgA

Mesh:

Substances:

Year:  2016        PMID: 27542871     DOI: 10.1016/j.yexcr.2016.08.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

Review 1.  MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.

Authors:  Piera Trionfini; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2017-02-23       Impact factor: 10.121

2.  MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?

Authors:  Haresh Selvaskandan; Izabella Pawluczyk; Jonathan Barratt
Journal:  Clin Kidney J       Date:  2017-09-23

3.  U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.

Authors:  Zhi-Yu Duan; Guang-Yan Cai; Ji-Jun Li; Ru Bu; NanNan Wang; Pei Yin; Xiang-Mei Chen
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

4.  MicroRNA‑379‑5p suppresses renal fibrosis by regulating the LIN28/let‑7 axis in diabetic nephropathy.

Authors:  Nan Li; Li-Juan Wang; Wei-Long Xu; Su Liu; Jiang-Yi Yu
Journal:  Int J Mol Med       Date:  2019-08-30       Impact factor: 4.101

Review 5.  The Role of MicroRNAs in Selected Forms of Glomerulonephritis.

Authors:  Magdalena Nalewajska; Klaudia Gurazda; Ewa Styczyńska-Kowalska; Małgorzata Marchelek-Myśliwiec; Andrzej Pawlik; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

6.  Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.

Authors:  Yaling Zhai; Yuanyuan Qi; Xiaoqing Long; Yanna Dou; Dong Liu; Genyang Cheng; Jing Xiao; Zhangsuo Liu; Zhanzheng Zhao
Journal:  J Cell Mol Med       Date:  2019-09-26       Impact factor: 5.310

7.  microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.

Authors:  Chan Liu; Mu-Yao Ye; Wen-Zhe Yan; Xiao-Fei Peng; Li-Yu He; You-Ming Peng
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

Review 8.  The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?

Authors:  Izabella Z A Pawluczyk; Haresh Selvaskandan; Jonathan Barratt
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

9.  Renal miR-148b is associated with megalin down-regulation in IgA nephropathy.

Authors:  Lu Wen; Zhanzheng Zhao; Jing Xiao; Zheng Wang; Xiangfei He; Henrik Birn
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

Review 10.  Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management.

Authors:  Haresh Selvaskandan; Sufang Shi; Sara Twaij; Chee Kay Cheung; Jonathan Barratt
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.